Boyanov & Co. has a strong foothold in the pharmaceuticals industry, where they advise international pharmaceutical and generics companies, namely AstraZeneca, AbbVie and Pfizer Bulgaria, on IP and trade mark rights, patent protection and litigation, price regulation and medical reimbursements, while also being well versed in related competition and antitrust matters. Kina Chuturkova and Peter Petrov jointly lead the practice, with the former specialising in litigation and arbitrations, and the latter handling regulatory advice and pharmaceutical antitrust. Nedyalka Novakova supports the team on a range of issues including day-to-day advice to pharma companies and contractual support for clinical trials.
Legal 500 Editorial commentary
- Profile